Microbot Medical Inc. (MBOT) NASDAQ
1.85
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.85
+0(+0.00%)
Currency In USD
| Previous Close | 1.85 |
| Open | 1.86 |
| Day High | 1.94 |
| Day Low | 1.84 |
| 52-Week High | 4.67 |
| 52-Week Low | 1.6 |
| Volume | 1.77M |
| Average Volume | 1.82M |
| Market Cap | 84.31M |
| PE | -7.12 |
| EPS | -0.26 |
| Moving Average 50 Days | 2.35 |
| Moving Average 200 Days | 2.52 |
| Change | 0 |
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
GlobeNewswire Inc.
Mar 10, 2026 12:30 PM GMT
Live Webcast on Thursday, March 19 at 8:40 am ET to Highlight the Expanding Clinical Experience with the LIBERTY® Endovascular Robotic System During the Limited Market ReleaseHINGHAM, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc.
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
GlobeNewswire Inc.
Mar 04, 2026 1:30 PM GMT
LIBERTY® Endovascular Robotic System’s Capability to Reduce Radiation Exposure Appeals to Hospitals and Healthcare ProvidersHINGHAM, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the in
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
GlobeNewswire Inc.
Mar 03, 2026 2:00 PM GMT
HINGHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that the Company, both in the USA and in Israel, is not exper